Hydrocodone For Pain Control in First Trimester Surgical Abortion
Completed · Phase 4 · Has a placebo group
Conditions studied: Pain
In brief
The purpose of this study is to determine whether preoperatively administered hydrocodone/acetaminophen (HC/APAP) reduces pain during a first trimester surgical abortion.
Key facts
- Study ID
- NCT01330459
- Run by
- Elizabeth Micks
- People needed
- 121
- Starts
- 2011-02-01
- Expected to finish
- 2011-10-01
- Last updated by the study team
- 2019-04-26
Who can join
Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Aged 18 years or older
- Voluntarily requesting surgical pregnancy termination
- Pregnancy with intrauterine gestational sac up to 10 weeks 6 days gestation, dated by ultrasound
- Eligible for suction curettage
- English or Spanish speaking
- Good general health
- Able and willing to give informed consent and agree to terms of the study
You may not qualify if…
- Gestational ages 11 weeks or more
- Incomplete abortion
- Premedication with misoprostol
- Use of any opioid medication within the past 7 days
- Use of heroin within the past 7 days
- Requested opioids or IV sedation prior to start of the procedure
- Patients who refuse ibuprofen or lorazepam
- Contraindications or allergies to HC/APAP, lidocaine, ibuprofen, or lorazepam
- Significant medical problem necessitating inpatient procedure
- Adnexal mass or tenderness on pelvic exam consistent with pelvic inflammatory disease
- Known hepatic disease
Where it is running
- Planned Parenthood CW — Portland, Oregon, United States
- Oregon Health & Science University — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.